Get the Stockscreener App
4.8211
3.19%
-0.1589
Scisparc Ltd stock is traded at $4.8211, with a volume of 4,743.
It is down -3.19% in the last 24 hours and up +42.22% over the past month.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
See More
Previous Close:
$4.98
Open:
$5
24h Volume:
4,743
Relative Volume:
0.01
Market Cap:
$2.76M
Revenue:
$927.00K
Net Income/Loss:
$-13.21M
P/E Ratio:
-0.0229
EPS:
-210.8843
Net Cash Flow:
$-4.77M
1W Performance:
-22.86%
1M Performance:
+42.22%
6M Performance:
-77.68%
1Y Performance:
+75.12%
1-Day Range:
$4.821
$5.00
1-Week Range:
$4.71
$6.465
52-Week Range:
$2.448
$80.10
Scisparc Ltd Stock (SPRC) Company Profile
Compare SPRC vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
4.8211 | 2.85M | 927.00K | -13.21M | -4.77M | -210.88 |
VRTX
Vertex Pharmaceuticals Inc
|
436.95 | 114.32B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
698.25 | 74.74B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
799.32 | 51.13B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
286.98 | 39.18B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
145.66 | 31.78B | 742.00K | -1.37B | -1.07B | -7.0731 |
Scisparc Ltd Stock (SPRC) Latest News
L.I.A. Pure Capital files 13G/A reporting - Stock Titan
Number of shareholders of SciSparc Ltd. – NASDAQ:SPRC - TradingView
TradingKey - TradingKey
SciSparc receives Nasdaq conditional compliance notice on listing requirements By Investing.com - Investing.com Australia
SciSparc receives Nasdaq conditional compliance notice on listing requirements - Investing.com
SciSparc Regains Conditional Nasdaq Compliance After Equity Shortfall - TipRanks
SciSparc (NASDAQ: SPRC) regains Nasdaq compliance but faces future test - Stock Titan
SPRC Stock Price, Quote & Chart | SCISPARC LTD (NASDAQ:SPRC) - ChartMill
SPRC - Finviz
Neurothera Labs Announces Continuance into Ontario - TheNewswire
SciSparc Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
SciSparc (NASDAQ: SPRC) 20-F shows widening losses and going concern risk - Stock Titan
SciSparc stock rallies after AutoMax files motion on pending merger - MSN
SPRC Technical Analysis | Trend, Signals & Chart Patterns | SCISPARC LTD (NASDAQ:SPRC) - ChartMill
Neurothera Labs Engages bullVestor for Investor Relations Activities - TheNewswire
SciSparc receives Nasdaq notice over stockholders’ equity shortfall - MSN
SPRC Stock Pops On Volatile Run As Traders Circle - timothysykes.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
SciSparc (SPRC) Stock Volume Ratio (Slips) 2026-04-20RSI Overbought Stocks - Cổng thông tin điện tử tỉnh Lào Cai
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
SPRC | SciSparc Ltd. Ordinary Shares Insider Trading - Quiver Quantitative
Amnon Ben Shay Net Worth (2026) - GuruFocus
Adi Zuloff Shani Net Worth (2026) - GuruFocus
Lior Vider Net Worth (2026) - GuruFocus
Is SciSparc (SPRC) Stock better than industry peers | Price at $3.02, Down 3.95%Community Sell Signals - newser.com
Block Trades: Can SciSparc Ltd scale operations efficientlyQuarterly Portfolio Summary & Breakout Confirmation Alerts - baoquankhu1.vn
Institution Moves: Can SciSparc Ltd outperform in the next rallyEntry Point & Community Verified Swing Trade Signals - baoquankhu1.vn
Market Trends: What makes SciSparc Ltd stock attractive todayOptions Play & Safe Entry Point Alerts - baoquankhu1.vn
MACD Signal: Is SciSparc Ltd impacted by rising ratesWeekly Risk Summary & Real-Time Buy Zone Alerts - baoquankhu1.vn
Institution Moves: Is SciSparc Ltd impacted by rising rates2026 Drop Watch & Breakout Confirmation Alerts - baoquankhu1.vn
Buyback Watch: Can SciSparc Ltd outperform in the next rallyWeekly Trade Analysis & Smart Allocation Stock Tips - baoquankhu1.vn
SPRC Should I Buy - Intellectia AI
Is SciSparc (SPRC) Stock sensitive to interest rates | Price at $3.54, Down 3.28%Stock Distribution - newser.com
SPRC Stock Analysis: SciSparc Ltd. Ordinary Shares biotech 0.41% dip at 3.66 view - UBND thành phố Hải Phòng
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Whale Trades: How correlated is SciSparc Ltd to the S P5002026 Macro Impact & Entry Point Confirmation Alerts - baoquankhu1.vn
SciSparc (SPRC) director Dayan Alon reports 3,651-share ownership stake - Stock Titan
SPRC SEC FilingsScisparc 10-K, 10-Q, 8-K Forms - Stock Titan
SciSparc (SPRC) director discloses shares, options and RSU awards - stocktitan.net
SciSparc (SPRC) director reports initial share and option holdings - Stock Titan
SciSparc (SPRC) director Revach Moshe discloses initial share and RSU holdings - Stock Titan
SciSparc (SPRC) CEO Adler Oz details share, option and RSU holdings - Stock Titan
SciSparc (SPRC) director Weiss Amitay details equity holdings - Stock Titan
SciSparc (SPRC) director Vider Lior details shares, options and RSUs - Stock Titan
SciSparc (SPRC) CTO details 5,528 Ordinary Shares and option holdings on Form 3 - Stock Titan
SciSparc (SPRC) director reports 3,651-share stake and RSU grants - Stock Titan
Sentiment Watch: Can SciSparc Ltd stock outperform in a bear marketRecession Risk & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Buyout Rumor: Is SciSparc Ltd impacted by rising ratesMarket Performance Report & Low Drawdown Investment Ideas - baoquankhu1.vn
SciSparc subsidiary files patent for depression treatment By Investing.com - Investing.com India
[SCHEDULE 13G] SciSparc Ltd. Passive Investment Disclosure (>5%) - Stock Titan
Scisparc Ltd Stock (SPRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):